Introduction
Hemodialysis exposes end-stage renal disease (ESRD) patients to significantly higher risks for hepatitis B virus (HBV) infection, a major public health scourge (1) (2) (3) (4) . Current US CDC guidelines and recommendations, last comprehensively revised in 2001, followed in US hemodialysis units, and simultaneously adhered to worldwide, among other recommendations, require monthly screening hepatitis B surface antigen (HBsAg) testing in all hemodialysis patients together with mandatory HBV vaccination of all hemodialysis patients (5) (6) (7) . Furthermore, the usual hepatitis B vaccination protocol calls for a series of three recombinant HbSAg vaccines given intramuscularly at 0, 1 and 6 months respectively. In 2010, we reported in the journal Renal Failure, the rare phenomenon of transient HbSAgenemia two days following Engerix B (GlaxoSmithKline) vaccination in an 81-year old Caucasian woman on (10) (11) (12) (13) (14) . Furthermore, our 2010 report also followed an Engerix B vaccine (8) . In this report, the patient had received his third Recombivax B vaccine instead. Notably, both Engerix B and Recombivax B vaccines are both recombinant antigen derived vaccines that have no association with human blood or blood products. It remains unclear why the preponderance of reports of transient post-vaccination HbSAgenemia have followed the Engerix B vaccine (8) (9) (10) (11) (12) (13) (14) .
Once again, as we posited in our 2010 report, we would want to reemphasize previous recommendations that patients who receive hepatitis B vaccinations should not be screened for HBsAg less than 4 weeks following a Hepatitis B vaccination (8, 9, 13) . The longest reported interval between an Engerix B vaccination and a positive HbSAg test was eighteen days in a 17-year old potential American male blood donor (15) . A misdiagnosis of a hepatitis B infection could lead to potentially harmful albeit unnecessary laboratory work up, unwarranted psychological stressors to the patient and family, and a feeling of anxiety and isolation for the patient as he will no longer be allowed to dialyze anywhere else in the dialysis unit except in the "dedicated" dialysis machines (8, 9, 15) . Moreover, at least theoretically, this misdiagnosis for a hemodialysis patient has the potential to increase the chances of the real vertical transmission of Hepatitis B to the patient from a truly hepatitis B patient by being dialyzed on the same "dedicated" machine (1-5). 
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